Recently, I also paid attention to the paper published in Nature in September 2026. If this hypothesis is ultimately validated in humans,
it would indeed be a very significant development.
The human body's functions are a very complex machine; cardiovascular protection, kidney protection, liver improvement, blood sugar improvement, inflammation reduction, cognitive improvement—these are not independent topics, but work systemically.
GLP-1, to some extent, changes "the speed of aging itself," which should benefit the system rather than just being useful for a particular organ. Eating less may be a key factor, but it is not the only factor.
Therefore, I do not agree that merely eating less can greatly extend lifespan. I have previously read a paper that suggested eating less is certainly beneficial for modern individuals, but everyone's health status is different, and it cannot be judged by a single factor.
Below are some main arguments from the paper that I have recorded:
In addition to reduced food intake, the decrease in fat reduces the burden on organs and lowers metabolic load. Semaglutide can also improve glucose tolerance and insulin sensitivity, while lowering IGF-1 and affecting the classic longevity pathway of insulin–IGF-1 → FOXO.
Moreover, semaglutide reduces inflammatory cytokines, highly expresses IL-6 in macrophages, and promotes inflammatory monocytes, while also lowering cellular aging markers such as p16 and p21, and improving mitochondrial and cellular repair systems.
So, if we visualize this as a logical chain, it might be:
GLP-1 activation
→ Appetite reduction / Metabolism improvement
→ Decreased fat and insulin burdens
→ NAD+↑ / SIRT↑ / IGF-1↓ / FOXO pathway changes
→ Inflammation↓ / Cellular aging↓ / Mitochondrial function↑ / Stem cell function↑
→ Multiple organs age more slowly
→ Healthspan ↑ → Lifespan ↑
This is much more complex than simply being long-lived due to weight loss or eating less.
Therefore, regardless of whether the AI + BIO reaches a critical point without narrative amplification, GLP-1 may begin to transition from treating diseases to intervening in the aging process itself, which I think could be of great significance to humanity.
免责声明：本文章仅代表作者个人观点，不代表本平台的立场和观点。本文章仅供信息分享，不构成对任何人的任何投资建议。用户与作者之间的任何争议，与本平台无关。如网页中刊载的文章或图片涉及侵权，请提供相关的权利证明和身份证明发送邮件到support@aicoin.com，本平台相关工作人员将会进行核查。
